MedTrace Logo

Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas

NCT04834609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2021-04-08

No results posted yet for this study

Summary

This study investigated the cellular and molecular characteristics of AT-MSCs obtained from autologous AT therapy in patients with high transphincteric perianal fistulas of crytoglandular origin. Adipose tissue was injected into anal fistulas. Characteristics of adipose tissue mesenchymal stemcells (AT-MSC) was investigated and compared in patients with fistula that healed after the treatment (responders) to patients who failed to heal (non-responders)

Conditions

  • Perianal Fistula
  • Adipose Tissue
  • Tissue Transplantation

Interventions

PROCEDURE

Injection of autologous adipose tissue in anal fistula

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • UiT The Arctic University of Norway

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-10-31
Completion
2021-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834609 on ClinicalTrials.gov